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Abstract: Endogenous leukotrienes (LT)
levels in plasma and urine samples, and LT
levels released from stimulated leukocytes in
vitro were examined in children with steroid
sensitive nephrotic syndrome (SSNS). Plasma
LT concentrations were found to be higher in
the SSNS group than in healthy subjects.
Subjects with SSNS were also shown to have
high levels of urinary cysteinyl-LTs and LTB ,
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while healthy children had only urinary LTE4
levels. In the second part of the study,

Introduction
The glomeruli are very sensitive to inflammatory
injury. Many studies are currently being done on cytokines
and inflammatory mediators in various types of renal
diseases. The spectrum of known proinflammatory
compounds originating from glomeruli has expanded
recently to include arachidonic acid-derived lipoxygenase
metabolites and platelet activating factor (PAF) (1, 2). In
recent experimental studies, the leukotrienes from the
arachidonic acid lipoxygenase pathway have been
demonstrated to play an important role in inflammatory
reactions in glomeruli after immune or nonimmune
injuries (3-5). The biological effects of cysteinylleukotrienes (LTs) (LTC4, LTD4 and LTE4) on the kidneys
include vasoconstriction, increase in arterial pressure,
decrease in renal blood flow (RBF) and glomerular
filtration rate (GFR), decrease in capillary pressure,
proteinuria, ultrafiltration, oliguria, and mesangeal cell
proliferation (4-7). LTC4 causes epithelial cell proliferation
and alters podocyte formation (8, 9). Nonpeptide LT
(LTB4), which is mostly released by endothelial cells, is a
chemotactic factor for leukocytes. It mediates cell
adhesion to endothelium and aggregation (6). Leukocytes
and glomerular cells release PAF, Thromboxan A2, major
basic
protein
(MBP),
prostoglandins,

peripheral leukocytes of patients and heatlhy
children were stimulated by Ca ionophore,
A23187. We detected significantly higher
levels of LTs in patients with SSNS suggest
that leukotrienes, with their biological
effects, might be involved in the pathogenesis
of steroid sensitive nephrotic syndrome.
Key Words: Steroid sensitive nephrotic
syndrome, inflammation, leukotrienes,
calcium ionophore.

hydroxyeicosatetraenoic acids (HETEs) and free radicals
after activation by LTB4. LTB4 increases the permeability
of the glomerular basement membrane (GBM), causes
proteinuria, and decreases RBF and GFR (7, 10, 11).
Changes in LT levels in immune glomerular diseases
have been implicated in many experimental studies by
different authors (4, 6, 12-14). In our previous clinical
studies, we determined increased urinary excretion of LTs
and increased amounts of various LTs released by the
leukocytes in different histopathological variants of
glomerulonephritis such as mesangeal proliferative or
membranoproliferative glomerulonephritis (15). The aim
of this study was to demonstrate the possible roles of LTs
in the pathophysiology of steroid-sensitive nephrotic
syndrome (SSNS) by detecting concentrations of them in
biological meterials.
Material and Methods
Patients: Seven patients (five male and two female,
mean age 5.4±4.8 years, range 2.5-16 years) with SSNS
hospitalized in the Department of Pediatric Nephrology of
Ege University between 1993 and 1994 were included in
the study in the acute period before the implementation
of steroid treatment. Diagnosis of SSNS was made
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Patient No.

Proteinuria

Age (years)

(mg/m /h)

2

Sex

Serum

Serum

Serum

GFR

albumin

T.Choles.

creatinine

(ml/min)

(g/L)

(mg/dl)

(mg/dl)

Table 1.

Clinicla status

1 (2.5, M)

72.5

20

295

0.7

80

First attack

2

(6, M)

95

25

386

0.9

129

First attack

3 (16, M)

93

23

661

0.8

128

Relaps, biopsy proven SSNS

4

(3, F)

52.5

25

486

0.4

144

First attack

5

(3, F)

60

24

486

0.6

81

Relaps, biopsy proven SSNS

6

(5, M)

52

25

370

0.4

133

First attack

7 (2.5, M)

75

24

565

0.3

153

Relaps, biopsy proven SSNS

71.4±

23±1

Mean±SD

17.8

464±

0.6±

121±

124.8

0.2

29

Laboratory and clinical data of
the children with SSNS

Control
Mean±SD

P value

ND

<0.05

50±4

<0.05

149.5

0.5±

124±

±24.6

0.1

35

<0.05

NS

NS: nonsignificant, ND: non detectable (less than 4 mg/m2/h))

according to the following criteria: 1) edema, 2) absence
of hematuria either macroscopic or microscopic, 3)
massive proteinuria (>40mg/m2 /h), 4) hypoalbuminemia
(<25g/L), 5) normo-complementemia, 6) selective
proteinuria, and 7) response to steroid. The clinical and
laboratory features of the patients are shown in Table 1.
Eight healthy children aged 3-14 years (mean 7 years,
two female and six male) with normal urine analysis
results and BUN levels were used as the control group.
Renal biopsy confirming minimal changes in glomeruli
had been performed on three of the patients. The mean
urinary protein concentration was 71.4±17.8 mg/m2 /h
(Table 1).
Methods
Leukotrienes were obtained from Plasma by solid
phase extraction using Sep-PAK C18 (Waters, Millford,
USA) cartridges. The urinary LTs were extracted by the
same method using Maxi-Clean C18-900 mg cartridges
(Altech, USA) (16). LTs were separet from the samples at
a flow rate of 1 ml/min in acetonitrile: water: methanol:
acetic acid gradient (300:420:100:0.8) at pH:5.1 in a
Waters HPLC system by Ultraspher ODS C18 (5 micron)
analytic columns (250x4.6 nm ID) and precolumns
(100x4.6 nm ID). The separation and retention time of
the LTs were obtained with the synthetic standards of
LTC4, LTD4, LTE4 and LTB4 (Sigma, St. Louis, USA). The
collected samples were dried under liquid nitrogen in a
vacuum speed concentrator.
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Quantitative measurement of LTs was done using
specific LT(H3 ) RIA kits (TRK-910, TRK-940, Amersham,
UK) and a b-liquid scintillation analyser system (TRICARB-1600 TR, LSA-Packard, Canberra Company).
Results were expressed as pmol/ml for plasma and
pmol/mg urine creatinine for urine.
Following preparation of the leukocyte suspension, it
was preincubated in a water bath at 37˚C and incubated
with A23187 for 15 min (17). At the end of incubation
the supernatant was separated by centrifugation and LTs
were extracted by using Sep-Pak C18 concentration
columns, as in the extraction of LTs from plasma. The
separation of LTs was performed by HPLC using
Ultrasphere ODS C18-5µ, 250x4.6mm analytic and
100x4.6mm guard columns in acetonitrile-water-TFA
eluent. Spectral analysis of LTs was done using synthetic
LTC4, LTD4, LTE4 and LTB4 standards (Sigma, St.Louis,
MO, USA). Amounts of LTs were measured by the
Baseline 815 HPLC Software System using PGB2 as an
internal standard for LTs. The results were expressed as
ng LT/107 leukocytes. The minimum detectable amount
was 1.0 ng/sample for all leukotrienes.
Statistics
Results are expressed as mean and standard deviation.
The Mann-Whitney test was used to analyze the
difference between patients with SSNS and controls. The
relationships between the parameters were tested by
regression analysis.
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Leukotrienes
Biological material

Groups

C4

D4

E4

B4

Plasma

Normal

ND

ND

ND

ND

(pMol/l)

SSNS

ND

ND

2.66±1.04

2.20±0.95

P value

NS

NS

<0.001

<0.001

Urine

Normal

ND

ND

0.07±0.01

ND

(pMol/mg creatinine)

SSNS

0.34±0.24

ND

1.10±0.37

0.58±0.23

P value

<0.001

NS

<0.01

<0.001

Table 2.

LT levels of plasma und urine
in SSNS patients and in
controls (Mean±SD)

Table 3.

LT levels released from
peripheral
leukocytes
stimulated in vitro by Ca+2
ionophore-A23187
(Mean±SD)

(ND: Nondetectale) (NS: Nonsignificant)

Leukotrienes
Biological material

Groups

C4

D4

E4

B4

Leukocytes stimulated

Normal

2.7±0.6

ND

ND

2.0±0.4

with A23187 in vitro

SSNS

15.5±5.4

0.8±0.5

7.1±3.8

18.1±6.5

p value

<0.01

<0.01

<0.001

<0.01

(5x107 )

ND: Nondetectable

Results
Leukotriene concentrations in the plasma and urine of
both the SSNS and the control groups are given in Tables
2 and 3. The level of urinary LTE4, a nonactive metabolite,
was 0.07±0.012 pMol/mg ceratinine in healthy children.
However, LTB4 and biologically active cysteinyl LTs (LTC4
and LTD4) were not detected in this group. Urinary LTE4
levels were found to be higher (mean 1.10±0.37, range
0.55-1.59 pMol/mg creatinine) in the SSNS group than in
the control group (p<0.01). Children with SSNS also had
significantly higher levels of urinary LTB4 (0.58±0.23
pMol/mg creatinine-range 0.29-0.85) and LTC4
(0.34±0.24 pMol/mg creatinine-range 0.10-0.52) than
the controls did (p<0.001). The daily urinary protein
excretion of the SSNS group had a significant positive
correlation with concentrations of urinary LTC4 (r=0.80,
p<0.05), LTE4 (r=0.77, p<0.05) and LTB4 (r=0.78,
p<0.05).
Patients in the SSNS group had significantly higher
(2.20±0.95 pMol/I) plasma LTB4 concentrations than the
controls (p<0.001). Plasma LTE4 levels were found to be
higher 2.66±1.04 pMol/I than in the controls (p<0.01).

Plasma LTE4 was alsofound to be correlated with
proteinuria (r=0.76, p<0.05).
The peripheral leukocytes of the healthy children were
demonstrated to release LTC4 and LTB4, but not LTD4 and
LTE4, after stimulation by Ca+2 ionophore-A23187.
Concentrations of LTC4 and LTB4 were found to be
2.7±0.6 ng/1x107 cells, and 2.0±0.4 ng/1x107 cells,
respectively. The leukocytes of the children with SSNS
were found to have markedly higher releasing activity of
LTC4, LTB4, LTD4 and LTE4, than those of the healthy
subjects (p<0.01, p<0.01, p<0.01, and p<0.001,
respectively) (Table 3). The levels of LTC4 and LTB4 were
15.5±5.4 ng/1x107 cells and 18.1±6.5 ng/1x107 cells in
the SSNS group. Healthy subjects had no detectable
amounts of LTD4 and LTE4.
Discussion
The proteinuria mechanism in nephrotic syndrome is
explained through a decrease in the anionic load of the
glomerular endothelial basement membrane and of the
epithelial foot processes. The factors determining
proteinuria caused by glomerular polyanion loss are not
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yet known. The aim of this clinical study was to examine
the possible roles of LTs in the pathogenesis of SSNS.
Endogenous LT concentrations in plasma and urine
samples were found to be higher in the SSNS group than
in the control group (Table 2). The urinary concentrations
of cysteinyl-LTs and LTB4 in SSNS group, and of LTE4 in
the heatlhy children were thought to be due to the
kidneys, since previous experimental studies
demonstrated that normal kidney tissue had substrates
and enzymes needed for LT spnthesis (3, 18).
Cysteinyl-LTs have contraction effects on smooth
muscles and endothelial cells. LTB4 has both direct and
indirect effects on GBM. The effects of LTs include
increased GBM permeability, decreased anionic load of
GBM, and leakage to microvascular space resulting in
local proteinuria and systemic edema (19-21). In this
study it was demonstrated that there were higher levels
of plasma and urinary LTB4 and cysteinyl-LTs in the urine
of the SSNS group, but not of LTs in the plasma of the
control group. We also found positive correlations
between proteinuria and urinary LTC4, LTD4, LTB4, and
plasma LTB4 in the same individual with SSNS, suggesting
that these biologically active substances might be related
to the development of proteinuria and adema.
The circulating polymorphonuclear and mononuclear
leukocytes that were activated in the glomeruli were
determined to play a role in anion load alterations of GBM
in the pathophysiology of SSNS (22). In both humans and
animals, peripheral leukocytes and glomerular cells
synthesize and release LTs when stimulated separately. In
this study in was thought that increased amounts of LTs

in plasma and urine might be released not only by
glomerular cells, but also by circulating leukocytes which
might be activated in glomeruli. For this purpose,
peripheral blood leukocytes of the SSNS group were
stimulated in vitro by Ca+2 ionophore A23187, and the LT
release in response to this stimulation was examined
(Table 3).
The substantial amounts of LTs released by the
cirulating leukocytes of the SSNS group in response to the
ionophore suggested that these cells were active and
functional, or that structural alterations occurred in their
cytoplasmic membranes. The determination of LT release
by peripheral leukocytes in vitro with high activity
suggests that the hypothesis of these leukocytes might be
activated by the LTs released from the injured glomerular
cells. Peripheral leukocytes have specific receptors of
cysteinyl-LTs and LTB4. LTs locally synthesized by
glomerular cells may activate intact leukocytes as well as
circulating leukocytes with their LT release in glomerulus
may also activate intact glomerulus and its cells.
Continuation of this activation cascade causes local
glomerular lesions, impairing GBM functions in particular.
Specific symptoms of nephrotic syndrome may occur by
their local effects.
In this study, endogenous LT concentrations in the
plasma and urine of SSNS patients were determined. It
was also demonstrated that the patient’s peripheral
leukocytes have a very high releasing capacity of
endogenous LTs when stimulated. On the basis of our
results and those reported in the literature, we propose
that LTs are importand mediators in the pathogenesis of
SSNS.
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